Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: J Cyst Fibros. 2010 Mar 15;9(3):212–216. doi: 10.1016/j.jcf.2010.02.004

Table 3.

Comparison of analyte results across normalization methods

Differences in Least square means (95% CI) Increase in CF patients compared to healthy controls Increase in CF patients compared to asthma subject change from admission to discharge in CF patients
Unadjusted analyte log(pmol/ml) 0.12 (−0.13, 0.37) −0.08 (−0.26, 0.09) −0.18 (−0.36, −0.01)
UCr regression adjusted analyte log(pmol/ml) 0.43 (0.30, 0.56) 0.25 (0.13, 0.36 ) −.006 (−0.09, 0.08)
SG regression adjusted analyte log(pmol/ml) UCr & SG regression 0.05 (−0.08, 0.18) ---- −0.14 (−0.23, −0.04)
adjusted analyte log(pmol/ml) 0.21 (0.08, 0.34) ---- −0.07 (−0.15, 0.01)

Values in bold indicate differences with p-values < 0.05

HHS Vulnerability Disclosure